Hip Fracture Exparel Administration Trial Capsule During Hemiarthroplasty
Status:
Unknown status
Trial end date:
2019-07-30
Target enrollment:
Participant gender:
Summary
This study will examine the efficacy of Liposomal Bupivacaine (Exparel) in hip fracture
patients undergoing hip hemiarthroplasty for femoral neck fractures through a posterior
approach. Post-operative measures will be assessing pain, overall opiate use, delirium,
time-to-ambulation and discharge status.